APA (7th ed.) Citation

Macaulay, R., & Anell, B. (2017). Nice and single? Recommendation Rates Of Oncology Therapies Approved On Clinical Trial Packages Lacking Comparative Phase 3 Data. Value in health, 20(9), A457. https://doi.org/10.1016/j.jval.2017.08.334

Chicago Style (17th ed.) Citation

Macaulay, R., and B. Anell. "Nice and Single? Recommendation Rates Of Oncology Therapies Approved On Clinical Trial Packages Lacking Comparative Phase 3 Data." Value in Health 20, no. 9 (2017): A457. https://doi.org/10.1016/j.jval.2017.08.334.

MLA (9th ed.) Citation

Macaulay, R., and B. Anell. "Nice and Single? Recommendation Rates Of Oncology Therapies Approved On Clinical Trial Packages Lacking Comparative Phase 3 Data." Value in Health, vol. 20, no. 9, 2017, p. A457, https://doi.org/10.1016/j.jval.2017.08.334.